|
1.
|
E WarnerClinical practice. Breast-cancer
screeningN Engl J
Med36510251032201110.1056/NEJMcp110154021916640
|
|
2.
|
C AggarwalN SomaiahGR SimonBiomarkers with
predictive and prognostic function in non-small cell lung cancer:
ready for prime time?J Natl Compr Canc Netw8822832201020679541
|
|
3.
|
Y TanSY MaFQ WangHP MengC MeiA LiuHR
WuProteomic-based analysis for identification of potential serum
biomarkers in gallbladder cancerOncol Rep26853859201121687958
|
|
4.
|
MS Abu-AsabM ChaouchiS AlesciS GalliM
LaassriAK CheemaF AtoufJ VanMeterH AmriBiomarkers in the age of
omics: time for a systems biology
approachOMICS15105112201110.1089/omi.2010.002321319991
|
|
5.
|
BK DunnPD WagnerD AndersonP
GreenwaldMolecular markers for early detectionSemin
Oncol37224242201010.1053/j.seminoncol.2010.05.00720709207
|
|
6.
|
JA LudwigJN WeinsteinBiomarkers in cancer
staging, prognosis and treatment selectionNat Rev
Cancer5845856200510.1038/nrc173916239904
|
|
7.
|
II WistubaJG GelovaniJJ JacobySE DavisRS
HerbstMethodological and practical challenges for personalized
cancer therapiesNat Rev Clin
Oncol8135141201110.1038/nrclinonc.2011.221364686
|
|
8.
|
S Schmitz-SpankeAW RettenmeierProtein
expression profiling in chemical carcinogenesis: a proteomic-based
approachProteomics11644656201110.1002/pmic.20100040321246732
|
|
9.
|
TY LauDP O’ConnorDJ BrennanMJ DuffySR
PenningtonWM GallagherBreast cancer proteomics: clinical
perspectivesExpert Opin Biol
Ther7209219200710.1517/14712598.7.2.20917250459
|
|
10.
|
H HondermarckC TastetI El
Yazidi-BelkouraRA ToillonX Le BourhisProteomics of breast cancer:
the quest for markers and therapeutic targetsJ Proteome
Res714031411200810.1021/pr700870c18311906
|
|
11.
|
D BöhmK KellerN WehrweinA LebrechtM
SchmidtH KölblFH GrusSerum proteome profiling of primary breast
cancer indicates a specific biomarker profileOncol
Rep2610511056201121837365
|
|
12.
|
M KadowakiT SangaiT NagashimaM SakakibaraH
YoshitomiS TakanoK SogawaH UmemuraK FushimiY NakataniF NomuraM
MiyazakiIdentification of vitronectin as a novel serum marker for
early breast cancer detection using a new proteomic approachJ
Cancer Res Clin
Oncol13711051115201110.1007/s00432-010-0974-921253761
|
|
13.
|
B BalluffM ElsnerA KowarschS RauserS
MedingC SchuhmacherM FeithK HerrmannC RöckenRM SchmidH HöflerA
WalchMP EbertClassification of HER2/neu status in gastric cancer
using a breast-cancer derived proteome classifierJ Proteome
Res963176322201010.1021/pr100573s21058730
|
|
14.
|
TC LaiHC ChouYW ChenTR LeeHT ChanHH ShenWT
LeeST LinYC LuCL WuHL ChanSecretomic and proteomic analysis of
potential breast cancer markers by two-dimensional differential gel
electrophoresisJ Proteome
Res913021322201010.1021/pr900825t20052998
|
|
15.
|
HJ IssaqTJ WaybrightTD VeenstraCancer
biomarker discovery: Opportunities and pitfalls in analytical
methodsElectrophoresis32967975201110.1002/elps.20100058821449066
|
|
16.
|
B WeigeltL PusztaiA AshworthJS
Reis-FilhoChallenges translating breast cancer gene signatures into
the clinicNat Rev Clin
Oncol95864201110.1038/nrclinonc.2011.12521878891
|
|
17.
|
CL SawyersThe cancer biomarker
problemNature452548552200810.1038/nature0691318385728
|
|
18.
|
CM SchlotterU VogtH AllgayerB
BrandtMolecular targeted therapies for breast cancer
treatmentBreast Cancer Res10211200810.1186/bcr211218671839
|
|
19.
|
H MukaiTargeted therapy in breast cancer:
current status and future directionsJpn J Clin
Oncol40711716201010.1093/jjco/hyq03720382634
|
|
20.
|
C Bernard-MartyF LebrunA AwadaMJ
PiccartMonoclonal antibody-based targeted therapy in breast cancer:
current status and future
directionsDrugs6615771591200610.2165/00003495-200666120-0000416956305
|
|
21.
|
SJ LiM PengH LiBS LiuC WangJR WuYX LiR
ZengSys-BodyFluid, a systematical database for human body fluid
proteome researchNucleic Acids
Res37D907D912200910.1093/nar/gkn84918978022
|
|
22.
|
JP da CunhaPA GalanteJE de SouzaRF de
SouzaPM CarvalhoDT OharaRP MouraSM Oba-ShinjaSK MarieWA Silva
JrBioinformatics construction of the human cell surfaceomeProc Natl
Acad Sci1061675216757200919805368
|
|
23.
|
J LiF LiuH WangX LiuJ LiuN LiF WanW WangC
ZhangS JinJ LiuP ZhuY LiuSystematic mapping and functional analysis
of a family of human epididymal secretory sperm-located proteinsMol
Cell Proteomics925172528201010.1074/mcp.M110.00171920736409
|
|
24.
|
HF DvorakVM WeaverTD TlstyG BergersTumor
microenvironment and progressionJ Surg
Oncol103468474201110.1002/jso.2170921480238
|
|
25.
|
RA GatenbyRJ GilliesWhy do cancers have
high aerobic glycolysis?Nat Rev
Cancer4891899200410.1038/nrc147815516961
|
|
26.
|
WH KoppenolPL BoundsCV DangOtto Warburg’s
contributions to current concepts of cancer metabolismNat Rev
Cancer113253372011
|
|
27.
|
H BandoM ToiK KitadaM KoikeGenes commonly
upregulated by hypoxia in human breast cancer cells MCF-7 and
MDA-MB-231Biomed
Pharmacother57333340200310.1016/S0753-3322(03)00098-214568227
|
|
28.
|
M OsakiM OshimuraH ItoPI3K-Akt pathway:
its functions and alterations in human
cancerApoptosis9667676200410.1023/B:APPT.0000045801.15585.dd15505410
|
|
29.
|
SE GhayadPA CohenInhibitors of the
PI3K/Akt/mTOR pathway: new hope for breast cancer patientsRecent
Pat Anticancer Drug
Discov52957201010.2174/15748921078970220819751211
|
|
30.
|
RZ OrlowskiEC DeesThe role of the
ubiquitination-proteasome pathway in breast cancer: applying drugs
that affect the ubiquitin-proteasome pathway to the therapy of
breast cancerBreast Cancer Res517200310.1186/bcr46012559038
|
|
31.
|
S RossiM LodaThe role of the
ubiquitination-proteasome pathway in breast cancer: use of mouse
models for analyzing ubiquitination processesBreast Cancer
Res51622200310.1186/bcr54212559040
|
|
32.
|
S LipkowitzThe role of the
ubiquitination-proteasome pathway in breast cancer: ubiquitin
mediated degradation of growth factor receptors in the pathogenesis
and treatment of cancerBreast Cancer
Res5815200310.1186/bcr54112559039
|
|
33.
|
PF McAuliffeF Meric-BernstamGB MillsAM
Gonzalez-AnguloDeciphering the role of PI3K/Akt/mTOR pathway in
breast cancer biology and pathogenesisClin Breast
Cancer10S59S65201010.3816/CBC.2010.s.01321115423
|
|
34.
|
AP StruckhoffMK RanaRA WorthylakeRhoA can
lead the way in tumor cell invasion and metastasisFront
Biosci1619151926201110.2741/383021196273
|
|
35.
|
S SengHK AvrahamS JiangS YangM SekineN
KimelmanH LiS AvrahamThe nuclear matrix protein, NRP/B, enhances
Nrf2-mediated oxidative stress responses in breast cancer
cellsCancer
Res6785968604200710.1158/0008-5472.CAN-06-378517875699
|
|
36.
|
TA MartinMD MasonWG JiangTight junctions
in cancer metastasisFront Biosci16898936200110.2741/3726
|
|
37.
|
SH KimJ TurnbullS GuimondExtracellular
matrix and cell signalling: the dynamic cooperation of integrin,
proteoglycan and growth factor receptorJ
Endocrinol209139151201110.1530/JOE-10-037721307119
|
|
38.
|
BP WijnhovenWN DinjensM
PignatelliE-cadherincatenin cell-cell adhesion complex and human
cancerBr J
Surg879921005200010.1046/j.1365-2168.2000.01513.x10931041
|
|
39.
|
G BerxF Van RoyThe E-cadherin/catenin
complex: an important gatekeeper in breast cancer tumorigenesis and
malignant progressionBreast Cancer
Res3289293200110.1186/bcr30911597316
|
|
40.
|
C TanP CostelloJ SangheraD DominguezJ
BaulidaAG de HerrerosS DedharInhibition of integrin linked kinase
(ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and
expression of the E-cadherin repressor, snail, in APC−/− human
colon carcinoma cellsOncogene20133140200111244511
|
|
41.
|
V BravouG KlironomosE PapadakiS TaravirasJ
VarakisILK over-expression in human colon cancer progression
correlates with activation of beta-catenin, down-regulation of
E-cadherin and activation of the Akt-FKHR pathwayJ
Pathol2089199200610.1002/path.186016278819
|
|
42.
|
V CortezBC NairD ChakravartyRK
VadlamudiIntegrin-linked kinase 1: role in hormonal cancer
progressionFront Biosci (Schol
Ed)3788796201110.2741/s18721196412
|
|
43.
|
A GrigoriadisOL CaballeroKS HoekL da
SilvaYT ChenSJ ShinAA JungbluthLD MillerD CloustonJ CebonLJ OldSR
LakhaniAJ SimpsonAM NevilleCT-X antigen expression in human breast
cancerProc Natl Acad
Sci1061349313498200910.1073/pnas.090684010619651608
|
|
44.
|
YM HusseinAF GharibRL EtewaAS El-ShalME
Abdel-GhanyWH ElsawyThe melanoma-associated antigen-A3, -A4 genes:
relation to the risk and clinicopathological parameters in breast
cancer patientsMol Cell
Biochem351261268201110.1007/s11010-011-0734-421264495
|
